• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类疱疹病毒与免疫检查点PD-1/PD-L1通路:疾病与生存策略

Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival.

作者信息

Murata Takayuki

机构信息

Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.

出版信息

Microorganisms. 2021 Apr 8;9(4):778. doi: 10.3390/microorganisms9040778.

DOI:10.3390/microorganisms9040778
PMID:33917804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068157/
Abstract

The immune system has evolved as a complex and efficient means of coping with extrinsic materials, such as pathogens and toxins, as well as intrinsic abnormalities, such as cancers. Although rapid and timely activation of the immune system is obviously important, regulated downregulation of the system is almost as significant as activation to prevent runaway immunity, such as allergies and hypercytokinemia. Therefore, the immune checkpoint programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is beneficial for the host. On the other hand, pathogens have evolved to evade host immunity by taking advantage of the PD-1/PD-L1 pathway. This review is focused on human herpesviruses, such as herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV), which cause various types of disorders, and their relationships with the PD-1/PD-L1 pathway. Understanding such relationships will be useful for developing preventative and therapeutic methods for disorders caused by herpesviruses.

摘要

免疫系统已经进化成为一种复杂而有效的应对外部物质(如病原体和毒素)以及内部异常(如癌症)的手段。虽然免疫系统的快速及时激活显然很重要,但该系统的调节性下调对于防止免疫失控(如过敏和高细胞因子血症)几乎与激活一样重要。因此,免疫检查点程序性细胞死亡1(PD-1)/程序性细胞死亡配体1(PD-L1)通路对宿主有益。另一方面,病原体已经进化到通过利用PD-1/PD-L1通路来逃避宿主免疫。本综述聚焦于人类疱疹病毒,如引起各种类型疾病的单纯疱疹病毒(HSV)、巨细胞病毒(CMV)和爱泼斯坦-巴尔病毒(EBV),以及它们与PD-1/PD-L1通路的关系。了解这些关系将有助于开发针对疱疹病毒引起的疾病的预防和治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8068157/cc8b8ddb4ceb/microorganisms-09-00778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8068157/cc8b8ddb4ceb/microorganisms-09-00778-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8068157/cc8b8ddb4ceb/microorganisms-09-00778-g001.jpg

相似文献

1
Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival.人类疱疹病毒与免疫检查点PD-1/PD-L1通路:疾病与生存策略
Microorganisms. 2021 Apr 8;9(4):778. doi: 10.3390/microorganisms9040778.
2
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.EB 病毒阳性原发性中枢神经系统淋巴瘤的血管周围微环境:程序性细胞死亡 1 和程序性细胞死亡配体 1 的作用。
Neuropathology. 2018 Apr;38(2):125-134. doi: 10.1111/neup.12435. Epub 2017 Oct 24.
3
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.移植后淋巴组织增生性疾病中程序性细胞死亡蛋白 1(PD1)/程序性细胞死亡配体 1(PD-L1)轴的临床病理评估:与 EBV、PD-L1 拷贝数改变和结局的关联。
Histopathology. 2019 Dec;75(6):799-812. doi: 10.1111/his.13857. Epub 2019 Oct 6.
4
A single tube PCR assay for simultaneous amplification of HSV-1/-2, VZV, CMV, HHV-6A/-6B, and EBV DNAs in cerebrospinal fluid from patients with virus-related neurological diseases.一种用于同时扩增病毒相关神经系统疾病患者脑脊液中单纯疱疹病毒1型/2型、水痘-带状疱疹病毒、巨细胞病毒、人疱疹病毒6A/6B和EB病毒DNA的单管PCR检测方法。
J Neurovirol. 2000 Oct;6(5):410-7. doi: 10.3109/13550280009018305.
5
Multi-layered control of PD-L1 expression in Epstein-Barr virus-associated gastric cancer.爱泼斯坦-巴尔病毒相关胃癌中PD-L1表达的多层调控
J Cancer Metastasis Treat. 2020;6(13). doi: 10.20517/2394-4722.2020.12. Epub 2020 May 23.
6
Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.爱泼斯坦-巴尔病毒相关鼻咽癌中PD-L1和PD-1表达及CD8 +肿瘤浸润淋巴细胞的特征分析
Am J Clin Oncol. 2018 Dec;41(12):1204-1210. doi: 10.1097/COC.0000000000000449.
7
[Prevention and therapy of herpesvirus infections].[疱疹病毒感染的预防与治疗]
Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):107-20.
8
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.EB 病毒编码的 EBNA2 通过下调 B 细胞淋巴瘤中的 miR-34a 来改变免疫检查点 PD-L1 的表达。
Leukemia. 2019 Jan;33(1):132-147. doi: 10.1038/s41375-018-0178-x. Epub 2018 Jun 26.
9
Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.卡波氏肉瘤相关疱疹病毒增加人单核细胞中 PD-L1 和促炎细胞因子的表达。
mBio. 2017 Oct 10;8(5):e00917-17. doi: 10.1128/mBio.00917-17.
10
EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions.EBV 相关胃癌通过 PD-1/PD-L1 相互作用逃避 T 细胞免疫。
Gastric Cancer. 2019 May;22(3):486-496. doi: 10.1007/s10120-018-0880-4. Epub 2018 Sep 28.

引用本文的文献

1
Early-Onset Ramsay Hunt Syndrome After Pembrolizumab Administration in a Patient With Lung Adenocarcinoma.一名肺腺癌患者在使用帕博利珠单抗后发生的早发型拉姆齐·亨特综合征。
Cureus. 2025 Jun 28;17(6):e86935. doi: 10.7759/cureus.86935. eCollection 2025 Jun.
2
Differential diagnosis in immune checkpoint inhibitors neurotoxicity.免疫检查点抑制剂神经毒性的鉴别诊断
J Neurol. 2025 Jan 15;272(2):116. doi: 10.1007/s00415-024-12872-6.
3
Targeted Delivery of BMS-1166 for Enhanced Breast Cancer Immunotherapy.用于增强乳腺癌免疫治疗的BMS-1166靶向递送

本文引用的文献

1
RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells.RNA测序分析确定EBNA2在爱泼斯坦-巴尔病毒感染原代B细胞过程中参与PD-L1的诱导。
Virology. 2021 May;557:44-54. doi: 10.1016/j.virol.2021.02.004. Epub 2021 Feb 21.
2
Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma.血管内大 B 细胞淋巴瘤中免疫检查点相关基因的频繁遗传改变。
Blood. 2021 Mar 18;137(11):1491-1502. doi: 10.1182/blood.2020007245.
3
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma.
Int J Nanomedicine. 2025 Jan 8;20:293-308. doi: 10.2147/IJN.S497089. eCollection 2025.
4
PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.PD-L1 表达在非细菌性慢性膀胱炎和膀胱癌中的研究
Int Urogynecol J. 2024 May;35(5):1069-1075. doi: 10.1007/s00192-024-05782-8. Epub 2024 Apr 25.
5
Advances in Alpha Herpes Viruses Vaccines for Human.人类α疱疹病毒疫苗的进展
Vaccines (Basel). 2023 Jun 12;11(6):1094. doi: 10.3390/vaccines11061094.
6
Immune checkpoint alterations and their blockade in COVID-19 patients.COVID-19患者的免疫检查点改变及其阻断
Blood Sci. 2022 Oct;4(4):192-198. doi: 10.1097/BS9.0000000000000132. Epub 2022 Aug 1.
7
Association of PD-1/PD-L1 expression and Epstein--Barr virus infection in patients with invasive breast cancer.PD-1/PD-L1 表达与 EBV 感染与浸润性乳腺癌患者的相关性。
Diagn Pathol. 2022 Jul 16;17(1):61. doi: 10.1186/s13000-022-01234-3.
8
Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity.程序性细胞死亡受体 1/程序性细胞死亡配体作为 2019 年冠状病毒病严重程度的预后标志物。
Cells. 2022 Jun 20;11(12):1978. doi: 10.3390/cells11121978.
针对鼻咽癌中的 PD-1/PD-L1 相互作用。
Oral Oncol. 2021 Feb;113:105127. doi: 10.1016/j.oraloncology.2020.105127. Epub 2021 Jan 14.
4
The cross-talk between STAT1/STAT3 and ROS up-regulates PD-L1 and promotes the release of pro-inflammatory/immune suppressive cytokines in primary monocytes infected by HHV-6B.STAT1/STAT3 与 ROS 的串扰上调 PD-L1 表达并促进 HHV-6B 感染原代单核细胞释放促炎/免疫抑制细胞因子。
Virus Res. 2021 Jan 15;292:198231. doi: 10.1016/j.virusres.2020.198231. Epub 2020 Nov 15.
5
Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation.溶瘤性疱疹病毒G47Δ的新辅助使用增强了射频消融的抗肿瘤疗效。
Mol Ther Oncolytics. 2020 Aug 21;18:535-545. doi: 10.1016/j.omto.2020.08.010. eCollection 2020 Sep 25.
6
The cytomegalovirus UL146 gene product vCXCL1 promotes the resistance of hepatic cells to CD8 T cells through up-regulation of PD-L1.巨细胞病毒 UL146 基因产物 vCXCL1 通过上调 PD-L1 促进肝细胞对 CD8 T 细胞的抵抗。
Biochem Biophys Res Commun. 2020 Nov 12;532(3):393-399. doi: 10.1016/j.bbrc.2020.08.060. Epub 2020 Aug 31.
7
Clinicopathological analysis of neoplastic PD-L1-positive EBV diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort.日本队列中肿瘤 PD-L1 阳性 EBV 弥漫性大 B 细胞淋巴瘤,非特指型的临床病理分析。
Virchows Arch. 2021 Mar;478(3):541-552. doi: 10.1007/s00428-020-02901-w. Epub 2020 Aug 15.
8
HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders.人疱疹病毒8型阳性、EB病毒阳性的霍奇金淋巴瘤样大B细胞淋巴瘤:扩大人疱疹病毒8型和EB病毒相关淋巴增殖性疾病的范围
Int J Hematol. 2020 Nov;112(5):734-740. doi: 10.1007/s12185-020-02897-8. Epub 2020 Jun 11.
9
The roles of programmed death ligand 1 in virus-associated cancers.程序性死亡配体1在病毒相关癌症中的作用。
Infect Genet Evol. 2020 Oct;84:104368. doi: 10.1016/j.meegid.2020.104368. Epub 2020 May 26.
10
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression.卡波西肉瘤相关疱疹病毒(KSHV)感染使巨噬细胞向 M2 样/TAM 极化,并激活 Ire1α-XBP1 轴,上调促肿瘤细胞因子的释放和 PD-L1 的表达。
Br J Cancer. 2020 Jul;123(2):298-306. doi: 10.1038/s41416-020-0872-0. Epub 2020 May 18.